The beneficial co-infection of HIV-1 infected patients with GBV-C or attenuated nef-deleted HIV-1 strain triggered exploring a different approach from the traditional vaccination for controlling HIV infection or disease progression. The gene discussed is S100B; the disease is HIV infectious disease.